{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:48:11Z","timestamp":1782395291480,"version":"3.54.5"},"reference-count":13,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>This case report describes the use of intravesicular amikacin irrigations to treat and prevent urinary tract infections (UTIs) in a pediatric patient with spina bifida and neurogenic bladder. A 15 year old Hispanic female was admitted for a UTI caused by Enterobacter cloacae and multiple-drug resistant Pseudomonas aeruginosa. A 7 day course of daily intravenous amikacin and ceftazidime was initiated along with twice daily intravesicular amikacin irrigations (15 mg\/30 mL) with a dwell time of 2 hours. The patient improved and was discharged on prophylactic Bactrim SS (sulfamethoxazole\/trimethoprim) 1 tablet daily and intravesicular amikacin irrigations (15 mg\/30 mL) once every other day. Approximately 2 months after discharge, the patient developed another UTI from multidrug resistant Escherichia coli and was treated with a 14 day course of daily intravenous ciprofloxacin accompanied by daily intravesicular amikacin irrigations. Adjunctive therapy with either once daily or twice daily intravesicular amikacin irrigations successfully treated the patient's UTI. However, prophylactic treatment with intravesicular amikacin failed to prevent future UTIs in this patient.<\/jats:p>","DOI":"10.5863\/1551-6776-16.2.102","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:15:59Z","timestamp":1603829759000},"page":"102-107","source":"Crossref","is-referenced-by-count":1,"title":["Use of Intravesicular Amikacin Irrigations for the Treatment and Prophylaxis of Urinary Tract Infections in a Patient with Spina Bifida and Neurogenic Bladder: A Case Report"],"prefix":"10.5863","volume":"16","author":[{"given":"Donna","family":"Huynh","sequence":"first","affiliation":[{"name":"University of Maryland School of Pharmacy, Baltimore, Maryland"},{"name":"University of Maryland Medical Center Children's Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"University of Maryland School of Pharmacy, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"1","key":"2020102716105329100_i1551-6776-16-2-102-b01","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.ju.0000146551.87110.f4","article-title":"Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey","volume":"173","author":"Elliott","year":"2005;","journal-title":"J Urology"},{"issue":"4","key":"2020102716105329100_i1551-6776-16-2-102-b02","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-008-1067-8","article-title":"Urinary tract infections in children with spina bifida: an inventory of 41 European centers","volume":"24","author":"Zegers","year":"2009;","journal-title":"Pediatr Nephrol"},{"issue":"7-8","key":"2020102716105329100_i1551-6776-16-2-102-b03","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1345\/aph.1D623","article-title":"Tobramycin bladder irrigation for treating a urinary tract infection in a critically ill patient","volume":"38","author":"Wood","year":"2004;","journal-title":"Ann Pharmacother"},{"issue":"10","key":"2020102716105329100_i1551-6776-16-2-102-b04","first-page":"1.218","article-title":"Continuous bladder irrigation with amikacin as adjuvant treatment for emphysematous cystitis","volume":"60","author":"Gonz\u00e1lez","year":"2007;","journal-title":"Arch Esp Urol"},{"issue":"3","key":"2020102716105329100_i1551-6776-16-2-102-b05","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10790268.2006.11753877","article-title":"Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder","volume":"29","author":"Waites","year":"2006;","journal-title":"J Spinal Cord Med"},{"issue":"5","key":"2020102716105329100_i1551-6776-16-2-102-b06","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0022-5347(05)00928-6","article-title":"Safety of gentamicin bladder irrigations in complex urological cases","volume":"175","author":"Defoor","year":"2005;","journal-title":"J Urology"},{"issue":"4","key":"2020102716105329100_i1551-6776-16-2-102-b07","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-5347(17)35725-7","article-title":"Neomycin toxicity in bladder irrigation","volume":"150","author":"de Jong","year":"1993;","journal-title":"J Urol"},{"issue":"4","key":"2020102716105329100_i1551-6776-16-2-102-b08","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-410X.1995.tb07750.x","article-title":"Neomycin-induced perception deafness following bladder irrigation in patients with end-stage renal disease","volume":"76","author":"Gerharz","year":"1995;","journal-title":"Br J Urol"},{"issue":"5","key":"2020102716105329100_i1551-6776-16-2-102-b09","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.22.5.819-821.1985","article-title":"Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms","volume":"22","author":"Larson","year":"1985;","journal-title":"J Clin Microbiol"},{"issue":"19","key":"2020102716105329100_i1551-6776-16-2-102-b10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/ajhp\/56.19.1929","article-title":"Current management of funguria","volume":"56","author":"Gubbins","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"2020102716105329100_i1551-6776-16-2-102-b11","first-page":"190","article-title":"Bedwetting and toileting problems in children","volume":"182","author":"Caldwell","journal-title":"MJA"},{"issue":"10","key":"2020102716105329100_i1551-6776-16-2-102-b12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.7863\/jum.2004.23.10.1307","article-title":"Sonographic evaluation of bladder volume in diabetic children and adolescents compared with nondiabetic subjects","volume":"23","author":"Castro","year":"2004;","journal-title":"J Ultrasound Med"},{"issue":"4","key":"2020102716105329100_i1551-6776-16-2-102-b13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MOU.0b013e32832c9178","article-title":"Management of pediatric neurogenic bladder","volume":"19","author":"MacLellan","year":"2009;","journal-title":"Curr Opin Urol"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/16\/2\/102\/1784173\/1551-6776-16_2_102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/16\/2\/102\/1784173\/1551-6776-16_2_102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:33:33Z","timestamp":1738780413000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/16\/2\/article-p102.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-16.2.102","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}